Cowen and Company’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Cowen and Company’s Portfolio GRNAW Stock Details GRNAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-47,681	Closed	-$2.44K	–	677
2023 Q1	$2.44K	Buy	+47,681	New	+$4.26K	﹤0.01%	515
2022 Q1	–	Sell	-52,931	Closed	-$64K	–	791
2021 Q4	$64K	Sell	52,931 -144,577	-73%	-$165K	0.01%	411
2021 Q3	$199K	Buy	+197,508	New	+$207K	0.01%	262
2021 Q2	–	Sell	-46,234	Closed	-$40K	–	758
2021 Q1	$40K	Buy	+46,234	New	+$48.2K	﹤0.01%	410

Other funds holding GRNAW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Cowen and Company's GRNAW Position: Q2 2023 in Review

Cowen and Company sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q2 2023, closing a stake of 47,681 shares — an estimated $2.44K sold.

Cowen and Company first reported a position in GRNAW in Q1 2021 and held it in 4 quarters. The position peaked at $199K in Q3 2021. 22 funds tracked by Wall St. Rank hold GRNAW as of Q2 2023.

Cowen and Company reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q2 2023 after selling out during the quarter.
Cowen and Company sold 47,681 GreenLight Biosciences Holdings, PBC Warrant shares in Q2 2023, an estimated $2.44K.
Cowen and Company first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q1 2021 and held it in 4 quarters.
Cowen and Company's GreenLight Biosciences Holdings, PBC Warrant position peaked at $199K in Q3 2021.
22 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q2 2023.

Based on Cowen and Company's 13F filing for Q2 2023, filed 7 Aug 2023.